arrow
Back
K

Kausik K. Ray

imperial college london

120H-index
839Paper Count
8.7WCitation Count
Published Papers 377
Publication Date
errShare
errSave
Potential impact on cholesterol goal achievement and predicted cardiovascular risk by the addition of ezetimibe and bempedoic acid on top of statins: A simulation from the SANTORINI study
err2026-03-24
err0
errOAAI
errKausik K. Ray; Carlos Aguiar; Marcello Arca; Derek L. Connolly; Mats Eriksson; Jean Ferrières; Ulrich Laufs; Jose M. Mostaza; David Nanchen; Charles Boachie; Ben Lee; Jarkko Soronen; Christian Becker; Ernst Rietzschel; Timo Strandberg; Hermann Toplak; Frank L.J. Visseren; Alberico L. Catapano
errShare
errSave
Obesity, metabolic health status, and adverse outcomes in men and women
err2026-03-14
err0
errOAAI
errRoshan A Ananda; Bethlehem Solomon; Stephen J Nicholls; Kausik K Ray
errShare
errSave
Low-Density Lipoprotein Cholesterol Lowering and Risk of Major Adverse Cardiovascular Events in Primary Prevention Trials: A Meta-Analysis
err2026-02-13
err0
errOAAI
errDinesh K. Kalra; Kausik K. Ray; Archna Bajaj; Pamela R. Kushner; Meredith L. Wilcox; Mary R. Dicklin; Carol F. Kirkpatrick; Kevin C. Maki
errShare
errSave
Lipid-lowering therapy and LDL cholesterol control among high- and very high-risk patients in Portugal: An analysis of the SANTORINI study
err2026-02-01
err1
errOAAI
errAguiar, Carlos; Aguiar, Patricio; Duarte, Joao Sequeira; Gil, Victor; Mimoso, Jorge; Monteiro, Pedro; Pinto, Fausto J.; Pinto, Fernando; Raposo, Joao; Von Hafe, Pedro; Ruivo, Jorge A.; Teixeira, Carla; Catapano, Alberico L.; Ray, Kausik K.
errShare
errSave
Corneal arcus and Achilles tendon thickness reflect circulating lipoprotein(a) levels in familial hypercholesterolemia: Implication for predicting future cardiovascular events
err2025-11-20
err0
PREAI
errKota Murai; Yu Kataoka; Kausik K. Ray; Sayaka Funabashi; Mika Hori; Masatsune Ogura; Takahito Doi; Hisashi Makino; Teruo Noguchi; Mariko Harada-Shiba
errShare
errSave
Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study
err2025-11-01
err0
errOAAI
errSki, Chantal F.; Jennings, Catriona S.; De Bacquer, Dirk; Kotseva, Kornelia; Mcevoy, John William; De Backer, Guy; Erlund, Iris; Ganly, Sandra; Vihervaara, Terhi; Lip, Gregory Yoke Hong; Ray, Kausik K.; Ryden, Lars; Adamska, Agnieszka; Abreu, Ana; Almahmeed, Wael; Ambari, Ade Meidian; Ge, Junbo; Hasan-Ali, Hosam; Huo, Yong; Jankowski, Piotr; Jimenez, Rodney M.; Li, Yong; Zuhdi, Ahmad Syadi Mahmood; Makubi, Abel; Mbakwem, Amam Chinyere; Mbau, Lilian; Estrada, Jose Luis Navarro; Ogah, Okechukwu Samuel; Ogola, Elijah Nyainda; Quintero-Baiz, Adalberto; Sani, Mahmoud Umar; Liprandi, Maria Ines Sosa; Tan, Jack Wei Chieh; Triana, Miguel Alberto Urina; Yeo, Tee Joo; Wood, David A.; Thompson, David R.
errShare
errSave
Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort
err2025-10-14
err0
PREAI
errMarcello Arca; Paolo Calabrò; Anna Solini; Angela Pirillo; Rosanna Gambacurta; Kausik K. Ray; Alberico L. Catapano
errShare
errSave
Lipid-lowering therapy treatment regimens in high- and very high-risk patients for the prevention of cardiovascular events: results from the Irish cohort of the multinational, observational SANTORINI study
err2025-10-01
err0
PREAI
errRai, Himanshu; Coughlan, John Joseph; O'callaghan, Daniel; Sheahan, Richard; Murphy, Ross; Burke, David; Mcfadden, Eugene; Nolan, Dermot; Colleran, Roisin; Hazeez-Agbaje, Abiola; Ray, Kausik K.; Catapano, Alberico L.; Byrne, Robert A.
errShare
errSave
Factors associated with elevated high-sensitivity C-reactive protein levels in individuals with atherosclerotic cardiovascular disease in the USA and the UK
err2025-10-01
err1
errOAAI
errRay, Kausik K.; Reuter, Simon Bertram; Dalbeler, Aysegul; Faurby, Mads D.; Letnar, Gasper; Mathisen, Jimmi; Nanna, Michael G.; Ng, Fu Siong; Pearson-Stuttard, Jonathan; Sattar, Naveed; Thompson, Andrew; Navar, Ann Marie
errShare
errSave
Usage of lipid-lowering therapies in patients at high and very high cardiovascular risk from Spain: one-year follow-up of the Spanish subpopulation from the European SANTORINI study
err2025-09-01
err1
errOAAI
errMostaza, J. M.; Lahoz, C.; Castro, M. Garcia de Yebenes; Campal, J. M. Rubio; Velasquez, E.; Gutierrez, A. Ibarra; Diaz, J. F.; Plana, N.; Rodriguez-Manero, M.; Garcia-Diaz, J. D. de Dios; Deben, F. Martinez; de Paz, I. Pavon; Catapano, A. L.; Moya, G. Diaz; Ray, K. K.
errShare
errSave
Association of Uric Acid-Lowering Therapies on Gout Frequency with Bempedoic Acid Clinical Insights From CLEAR Outcomes
err2025-09-01
err0
errOAAI
errRay, Kausik K.; Nicholls, Stephen J.; Lincoff, A. Michael; Li, Na; Powell, Heather A.; Herout, Peter M.; Bloedon, LeAnne; Nissen, Steven E.
errShare
errSave
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients
errJACC
IF0
err2025-09-01
err0
errOAAI
errStephen J. Nicholls; Adam J. Nelson; Kausik K. Ray; Christie M. Ballantyne; Marc Ditmarsch; Douglas Kling; Andrew Hsieh; Michael Szarek; John J. Kastelein; Michael H. Davidson
errShare
errSave
Lipoprotein(a) identifies patients with acute coronary syndromes who derive cardiovascular benefit from alirocumab, particularly for limb events
errJACC
IF0
err2025-08-27
err0
PREAI
errKausik K. Ray; Michael Szarek; Deepak L. Bhatt; Vera A. Bittner; Sergio Fazio; Shaun G. Goodman; Robert A. Harrington; J. Wouter Jukema; Harvey D. White; Ph. Gabriel Steg; Gregory G. Schwartz
errShare
errSave
Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial
err2025-08-20
err0
errOAAI
errStephen J. Nicholls; Kausik K. Ray; A. Michael Lincoff; Evelyn Sarnes; Kristin K. Gillard; LeAnne Bloedon; Kristen Migliaccio-Walle; David Elsea; Steven E. Nissen
errShare
errSave
Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis
err2025-08-19
err0
errOAAI
errJedidiah I. Morton; Florian Kronenberg; Magdalena Daccord; Nicola Bedlington; Marius Geanta; Tobias Silberzahn; Zhenyue Chen; Jean-Luc Eisele; Bogi Eliasen; Mariko Harada-Shiba; Marc Rijken; Albert Wiegman; George Thanassoulis; Pia R. Kamstrup; Iñaki Gutierrez-Ibarluzea; Pablo Coral; Raul D. Santos; Erik Stroes; Michal Vrablik; Gerald F. Watts; Christie M. Ballantyne; Samia Mora; Børge G. Nordestgaard; Kausik K. Ray; Stephen J. Nicholls; Zanfina Ademi
errShare
errSave
Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE
err2025-08-01
err1
PREAI
errCegla, Jaimini; Jennings, Catriona; Kenny, Eanna; De Bacquer, Dirk; Ray, Kausik Kumar; Corry, John-Paul; Adamska, Agnieszka; Kotseva, Kornelia; Mcevoy, John W.; Noone, Chris; Ganly, Sandra; Alali, Juwairia; Al Mahmeed, Wael; Bazargani, Nooshin; Ge, Junbo; Jong, Rose Hui-Chin; Foo, Diana Hui-Ping; Huo, Yong; Bonilla, Paula Luna; Ji, Nancy Xinrong; Jankowski, Piotr; Li, Yong; Mbakwem, Amam; Mbau, Lilian Kagure; Ogah, Okechukwu Samuel; Ogola, Elijah N.; Quintero-Baiz, Adalberto Elias; Sani, Mahmoud Umar; Urina-Triana, Miguel A.; Wolfshaut-Wolak, Renata; Zuhdi, Ahmad Syadi Mahmood; Wood, David Allan
errShare
errSave